The association between depressive symptoms and acute exacerbations of COPD.

scientific article published on 7 February 2009

The association between depressive symptoms and acute exacerbations of COPD. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00408-009-9135-9
P8608Fatcat IDrelease_cx6vcaogofannbdfmcgsoxbv2y
P698PubMed publication ID19198940

P50authorJeffrey H JenningsQ83308791
P2093author name stringBruno Digiovine
Cathy Frank
Dany Obeid
P2860cites workRandomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialQ24642534
The MOS 36-ltem Short-Form Health Survey (SF-36)Q26778425
An Inventory for Measuring DepressionQ26778503
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity SurveyQ28258215
Smoking, smoking cessation, and major depressionQ28296708
A new method of classifying prognostic comorbidity in longitudinal studies: development and validationQ29547376
Standardization of Spirometry, 1994 Update. American Thoracic SocietyQ29547574
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseQ29618681
Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic reviewQ33691278
Cytokine-induced sickness behavior.Q33964676
The relationship of depression and stressors to immunological assays: a meta-analytic reviewQ34375707
Treatment non-adherence in affective disorders.Q34592227
The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trialsQ34727099
Chronic disease as a barrier to breast and cervical cancer screeningQ34751931
HIV disease progression: depression, stress, and possible mechanismsQ35189658
Risk of depression in patients with chronic obstructive pulmonary disease and its determinants.Q35535166
Improving antidepressant adherence.Q35618701
Stress, depression, the immune system, and cancerQ35909595
Sex differences in severe pulmonary emphysemaQ36013675
Prevalence and impact of depression in chronic obstructive pulmonary disease patientsQ36385816
Progression to AIDS: the effects of stress, depressive symptoms, and social supportQ39510401
The association between depressive symptoms and cigarette smoking in an urban primary care sampleQ39542134
Frequent hospital readmissions for acute exacerbation of COPD and their associated factorsQ43176961
Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.Q43942974
Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizationsQ43963238
Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE studyQ44198467
Acute infective exacerbations of chronic bronchitis.Q44712511
Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary diseaseQ45045303
Smoking and major depression. A causal analysisQ45093345
Effect of race on patient expectations regarding their primary care physiciansQ46864535
Functional impairment in COPD patients: the impact of anxiety and depressionQ47619815
Risk factors for hospital readmission in patients with chronic obstructive pulmonary diseaseQ47730495
Risk factors for rehospitalisation in COPD: role of health status, anxiety and depressionQ47735791
Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.Q50680798
Longitudinal changes in the nature, severity and frequency of COPD exacerbations.Q50735282
Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with COPD.Q50900677
Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease.Q51035658
Prevalence of depression and anxiety in patients with COPD. Relationship to functional capacity.Q51226734
Mortality after hospitalization for COPD.Q51717351
Validation of 2 depression screening tools in dialysis patients.Q51924711
Screening for depression in diabetes using the Beck Depression Inventory.Q52005404
Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.Q53577143
Associations of depressive symptoms with gender, body mass index and dyspnea in primary care COPD patientsQ57313675
Relationship Between Bacterial Flora in Sputum and Functional Impairment in Patients With Acute Exacerbations of COPDQ57778537
Relationship between depression and exacerbations in COPDQ62111233
Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of lifeQ66829665
Recognition of depression in patients who smokeQ67958013
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic SocietyQ71796390
Depressive symptoms and CD4 lymphocyte decline among HIV-infected menQ72656764
Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaireQ73444623
The association between depressive symptoms and health status in patients with chronic pulmonary diseaseQ73784422
Prevalence of depressive symptoms and depression in patients with severe oxygen-dependent chronic obstructive pulmonary diseaseQ73788335
Inflammatory changes, recovery and recurrence at COPD exacerbationQ79362620
The validity of the Beck Depression Inventory-Short Form as a screening and diagnostic instrument for moderate and severe depression in medical inpatientsQ81632201
P433issue2
P921main subjectchronic obstructive pulmonary diseaseQ199804
P304page(s)128-135
P577publication date2009-02-07
P1433published inLungQ15765075
P1476titleThe association between depressive symptoms and acute exacerbations of COPD
P478volume187